Edgewise Therapeutics (EWTX) Interest Expenses (2020 - 2025)
Edgewise Therapeutics (EWTX) posted Interest Expenses of $3.8 million for Q4 2025, down 17.39% sequentially from $4.6 million in Q4 2024, and down 17.39% YoY from $4.6 million in Q4 2024.
Edgewise Therapeutics (EWTX) Interest Expenses (2020 - 2025) Analysis & Trends
Edgewise Therapeutics has reported Interest Expenses for 6 years, with the latest figure at $3.8 million in Q4 2025.
- Quarterly Interest Expenses fell 17.39% year-over-year to $3.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.8 million (down 17.39% YoY) and the FY2025 annual result came in at $255.7 million, down 4.36% from the prior year.
- Interest Expenses retreated to $3.8 million in Q4 2025 per EWTX's latest filing, from $4.6 million in the prior quarter.
- Over five years, Interest Expenses peaked at $7.1 million in Q1 2023 and troughed at $53000.0 in Q4 2023.
- A 5-year average of $2.8 million and a median of $1.3 million in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2021 and 2024: Interest Expenses plunged 98.41% in 2021, then soared 8579.25% in 2024.
- Over 5 years, Interest Expenses stood at $141000.0 in 2021, then surged by 206.38% to $432000.0 in 2022, then tumbled by 87.73% to $53000.0 in 2023, then jumped by 8579.25% to $4.6 million in 2024, then decreased by 17.39% to $3.8 million in 2025.
- According to Business Quant data, Interest Expenses over the past three periods registered $3.8 million, $4.6 million, and $1.1 million for Q4 2025, Q4 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Edgewise Therapeutics | 4.76 Bn | 4.76 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.80 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Dec 31, 2024 | 4.60 Mn |
| Dec 31, 2024 | 4.60 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 6.37 Mn |
| Mar 31, 2024 | 6.37 Mn |
| Dec 31, 2023 | 53,000.00 |
| Dec 31, 2023 | 53,000.00 |
| Sep 30, 2023 | 1.29 Mn |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 7.03 Mn |
| Jun 30, 2023 | 7.03 Mn |
| Mar 31, 2023 | 7.09 Mn |
| Mar 31, 2023 | 7.09 Mn |
| Dec 31, 2022 | 432,000.00 |
| Dec 31, 2022 | 432,000.00 |
| Sep 30, 2022 | 705,000.00 |
| Sep 30, 2022 | 705,000.00 |